| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_308c1d369c0e631eb0885773050a14e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-908 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48758102679601801e28a1e499fd4826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51440b67e9ec4e12f9f833213ba3964f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989fba633573c442b14df4076a8537bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d8c6c06f7ba2d657df8e4ffecd4bae2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_719382b26beb0c6735230a3a13dee5cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c487434a83974450161e49d538a115b |
| publicationDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101863508-B1 |
| titleOfInvention |
Kit for liver cirrhosis or liver cancer specific diagnosis comprising monoclonal antibody AGP501 against asialo α-1 acid glycoprotein and RCAⅡ-HRP conjugates and uses thereof |
| abstract |
The present invention relates to a cirrhotic or liver cancer-specific diagnostic kit comprising a single antibody AGP501 and an RCAII-HRP conjugate to an alpha-1 acid glycoprotein, and its use. Through the present invention, an accurate diagnosis of cirrhosis and liver cancer, Early detection of liver cancer and treatment can be facilitated. Currently, there are no in vitro diagnostic reagents for early diagnosis of cirrhosis through blood. AFP is used in the diagnosis of liver cancer, but the rate of positive for liver cancer is very low. Through commercialization of AsAGP, a diagnostic kit for cirrhosis and liver cancer using the technique of the present invention, it will be widely supplied to domestic and overseas specialized medical institutions, and will contribute to the development of medical device industry and diagnostic medicine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102269748-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210052751-A |
| priorityDate |
2017-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |